A 37-year-old woman with HIV returns to clinic after being out of care for several years. Previously, she received a regimen of boosted atazanavir with tenofovir DF-emtricitabine, but experienced virologic breakthrough (HIV RNA 2,980 copies/mL). A genotype was performed at the time and showed only a reverse transcriptase M184V mutation.